Scaling AI-Driven Pathology into Clinical and Commercial Diagnostics
Format: 1-hour Virtual Interest Group Session
Date & Time: 10th March 2026, 15.30–16.30 PM UK / 10.30 – 11.30 am EST
Platform: Zoom
15.30 PM – Thought Leader Interview
Duration: 15 minutes
Title: The Emerging Era of Computational Precision Biomarkers
Interview with: Eric Walk, Chief Medical Officer, PathAI
15.45 PM – Thought Leader Interview
Duration: 15 minutes
Title: Pioneering the Future of Diagnostics: AI and Innovation in Pathology
Interview with: Dr. Muhammed Aslam, Consultant Pathologist, Betsi Cadwaladr University Health Board; Clinical Lead for Wales Digital Pathology/AI
16.00 PM – Panel Discussion
Title: Computational Precision Biomarkers & Spatial Pathology - The Next Frontier in Precision Diagnostics
Duration: 30 minutes
Key Themes:
- Integrating AI in CDx, spatial pathology, and translational data - Integrating AI in CDx, spatial pathology and how translational data informs diagnosis, prognosis, and treatment strategies.
- Scaling innovation across public and private sectors: collaborations between the NHS, biotech, AI startups, and healthtech; the role of leadership in aligning efforts.
- Opportunities in Precision Biomarkers and Commercialisation
Moderated by Darren Davis, Director, Precision for Medicine
Panellists:
John Le Quesne, Professor, University of Glasgow
Eric Walk, Chief Medical Officer, PathAI
Muhammed Aslam, Consultant Pathologist, Betsi Cadwaladr University Health Board; Clinical Lead for Wales Digital Pathology/AI
To attend this Thought Leadership session you need to be a Premium LifeScienceXchange member.
Secure all the benefits and sign-up for Premium membership now
*If you’re already a Premium member your exclusive invite will be sent direct to your inbox